Literature DB >> 11926949

Abnormal motility in patients with ulcerative colitis: the role of inflammatory cytokines.

Matthew D Vrees1, Victor E Pricolo, Fabio M Potenti, Weibiao Cao.   

Abstract

HYPOTHESIS: Interleukin 1 beta (IL-1 beta) levels are elevated in the colonic mucosa of patients with ulcerative colitis (UC). We propose that IL-1 beta may also be elevated in the circular muscle layer of the colon and may be partially responsible for the motility dysfunction observed in patients with UC.
DESIGN: Cohort analytic study.
SETTING: Research laboratory in a tertiary academic medical center. PARTICIPANTS: Normal smooth muscle was obtained from the disease-free margins of human sigmoid colon specimens resected from patients with cancer and compared with specimens from patients with UC.
INTERVENTIONS: An enzyme-linked immunosorbent assay was used to measure IL-l beta. Standard muscle chambers were used to measure force changes. Single muscle cells were isolated by enzymatic digestion, and cell shortening in response to neurokinin A (NKA) and thapsigargin was measured under a microscope. Cytosolic Ca(2+) (calcium) concentrations were measured by standard techniques. MAIN OUTCOME MEASURE: Effects of IL-1 beta on smooth muscle function in normal and UC colons.
RESULTS: In patients with UC, IL-1 beta was elevated in the muscularis propria, and sigmoid circular smooth muscle contractions in response to NKA and thapsigargin were significantly reduced. In fura-2-loaded cells from patients with UC, the NKA-induced Ca(2+) signal was also significantly reduced in Ca(2+)-free medium, indicating the reduced intracellular Ca(2+) stores after UC. Exposure of normal cells to IL-1 beta mimicked the changes observed in patients with UC. An IL-1 beta-induced reduction in contraction and release of intracellular Ca(2+) in response to NKA was partially restored by the hydrogen peroxide scavenger catalase.
CONCLUSION: In patients with UC, IL-1 beta was increased in colonic circular muscles and may contribute to motor dysfunction after UC through production of hydrogen peroxide.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11926949     DOI: 10.1001/archsurg.137.4.439

Source DB:  PubMed          Journal:  Arch Surg        ISSN: 0004-0010


  29 in total

1.  Cytokine-induced alterations of gastrointestinal motility in gastrointestinal disorders.

Authors:  Hirotada Akiho; Eikichi Ihara; Yasuaki Motomura; Kazuhiko Nakamura
Journal:  World J Gastrointest Pathophysiol       Date:  2011-10-15

2.  Identification of histamine receptors and effects of histamine on murine and simian colonic excitability.

Authors:  H Kim; L Dwyer; J H Song; F E Martin-Cano; J Bahney; L Peri; F C Britton; K M Sanders; S D Koh
Journal:  Neurogastroenterol Motil       Date:  2011-08-01       Impact factor: 3.598

Review 3.  Gastrointestinal motility disorders in inflammatory bowel diseases.

Authors:  Gabrio Bassotti; Elisabetta Antonelli; Vincenzo Villanacci; Marianna Salemme; Manuela Coppola; Vito Annese
Journal:  World J Gastroenterol       Date:  2014-01-07       Impact factor: 5.742

Review 4.  Intestinal dysmotility in inflammatory bowel disease: mechanisms of the reduced activity of smooth muscle contraction.

Authors:  Hiroshi Ozaki; Masatoshi Hori; Kazuya Kinoshita; Takashi Ohama
Journal:  Inflammopharmacology       Date:  2005       Impact factor: 4.473

5.  MAPKs represent novel therapeutic targets for gastrointestinal motility disorders.

Authors:  Eikichi Ihara; Hirotada Akiho; Kazuhiko Nakamura; Sara R Turner; Justin A Macdonald
Journal:  World J Gastrointest Pathophysiol       Date:  2011-04-15

Review 6.  Colonic motility in ulcerative colitis.

Authors:  Gabrio Bassotti; Elisabetta Antonelli; Vincenzo Villanacci; Monia Baldoni; Maria Pina Dore
Journal:  United European Gastroenterol J       Date:  2014-12       Impact factor: 4.623

7.  Twenty-four-hour manometric study of colonic propulsive activity in patients with diarrhea due to inflammatory (ulcerative colitis) and non-inflammatory (irritable bowel syndrome) conditions.

Authors:  Gabrio Bassotti; Giuseppe de Roberto; Fabio Chistolini; Francis Sietchiping-Nzepa; Olivia Morelli; Antonio Morelli
Journal:  Int J Colorectal Dis       Date:  2004-04-09       Impact factor: 2.571

8.  Exogenous interleukin-6 facilitated the contraction of the colon in a depression rat model.

Authors:  Li Zhang; Liudan Hu; Mingkai Chen; Baoping Yu
Journal:  Dig Dis Sci       Date:  2013-04-16       Impact factor: 3.199

9.  Upregulation of RGS4 and downregulation of CPI-17 mediate inhibition of colonic muscle contraction by interleukin-1beta.

Authors:  Wenhui Hu; Sunila Mahavadi; Fang Li; Karnam S Murthy
Journal:  Am J Physiol Cell Physiol       Date:  2007-10-24       Impact factor: 4.249

10.  Paradoxical regulation of ChAT and nNOS expression in animal models of Crohn's colitis and ulcerative colitis.

Authors:  John H Winston; Qingjie Li; Sushil K Sarna
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2013-05-16       Impact factor: 4.052

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.